| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a20dcaa02f0e633aff4837ba946bd0de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b7f1a717a71f61eac5e9a9340dd42fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f83fde929c571c1fc52228110e55adfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a283598edbec905da7ba220370723c4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate |
1995-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a7492b771b795dc79dcec84f4c58dd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5edbb5b7405c21aa590d57c6893bbdc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90a963b1a6829dbb0f5c755923088350 |
| publicationDate |
1996-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9609063-A1 |
| titleOfInvention |
Use of muramyl peptide compounds |
| abstract |
Certain muramyl peptide derivatives such as GMDP find particular use in the treatment of ophthalmic conditions such as herpetic keratitis and herpetic keratouveitis. The muramyl peptide derivatives are particularly useful for reducing or preventing corneal scarring which may occur as a result of conditions such as keratitis. Treatment with muramyl peptide compounds may be used in addition to treatment with other drugs. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9705890-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2198723-A1 |
| priorityDate |
1994-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |